Interstitial Lung Disease Market to Witness Strong Growth Amid Diagnostic and Therapeutic Advancements – BIS Research

What Is the Market Outlook? 

The ILD market is entering a phase of sustained innovation with the development of high-resolution diagnostic tools and targeted therapeutics. With limited treatment options historically available, stakeholders are now witnessing a shift toward personalized medicine, biomarker discovery, and digital health integration. Government and private investments in pulmonary health research are also expanding access to early screening programs. 

How Fast Is the Market Growing? 

According to BIS Research, the ILD market is projected to grow steadily through the forecast period, driven by increased diagnostic testing, awareness campaigns, and clinical trials focusing on both idiopathic and non-idiopathic ILDs. 

How Will This Report Help You? 

Planning to Enter the Market? 

Gain insights into unmet needs in pulmonary diagnostics and emerging growth opportunities in AI-integrated radiology and pathology. 

Analyzing the Competitive Landscape? 

Evaluate pharmaceutical and biotech players advancing antifibrotic therapies and inhalable drug delivery systems. 

Seeking R&D Insights? 

Explore biomarker-based research, AI applications in HRCT imaging, and molecular profiling approaches enhancing early detection. 

Interested in Regional Market Trends? 

Access regional and country-level analysis across North America, Europe, Asia-Pacific, and the Rest-of-the-World. 

Explore the Full TOC and Download Report Sample 

What Technologies Are Transforming the Market? 

• High-Resolution Computed Tomography (HRCT) for precise lung imaging 
• Artificial intelligence and machine learning for radiological interpretation 
• Liquid biopsies and genomic sequencing for early disease markers 
• Antifibrotic therapeutics and inhaled biologics 
• Digital health monitoring tools for patient adherence and remote care 

What’s Driving Demand and What Are the Barriers? 

Drivers: 

• Rising incidence of fibrotic lung diseases globally 
• Advancements in non-invasive and AI-supported diagnostic technologies 
• Increasing availability of disease-modifying treatments 
• Government funding for rare disease research and awareness 

Restraints: 

• High cost of advanced diagnostics and therapeutics 
• Diagnostic delays due to symptom overlap with other respiratory diseases 
• Limited expertise in ILD management in primary care 

Opportunities: 

• Expanding telemedicine and remote diagnostic services 
• AI integration for early HRCT scan analysis and disease staging 
• Personalized treatment protocols through omics-based data 
• Regional partnerships for diagnostic infrastructure development 

How Is the Market Segmented? 

by Region 

• North America 

• Europe  

• Asia-Pacific 

• Rest-of-the-World 

Who Are the Key Players in the Market? 

• Boehringer Ingelheim GmbH 

• F. Hoffmann-La Roche Ltd 

• Glenmark Pharmaceuticals Ltd. 

• Cipla Ltd. 

Strategic Moves Shaping the Future: 

Pharmaceutical giants are expanding clinical trials for antifibrotics while diagnostic tech companies are investing in AI-powered platforms for radiology. Collaborations between imaging tech firms and academic institutions are fueling biomarker discovery and innovation in non-invasive testing methods. 

Download the Complete TOC now! 

Case Insight: Roche and Boehringer in Antifibrotic Therapy Development 

Both Roche (with Esbriet) and Boehringer Ingelheim (with Ofev) have developed antifibrotic therapies approved for IPF, offering patients improved life expectancy and slower disease progression. These drugs are now being tested in broader ILD indications and combination therapies, reflecting industry focus on expanded treatment pipelines. 

Schedule a Call with Industry Experts 

Related Reports from BIS Research 

Global B Rapidly Accelerated Fibrosarcoma Metastatic Non-small Cell Lung Cancer Market 

Ascites Market 

Europe Digital Surgery Technologies Market 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing  

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686  

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch